Amedisys, Inc. (NASDAQ:AMED) Shares Bought by Parallel Advisors LLC

Parallel Advisors LLC raised its holdings in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 447.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,394 shares of the health services provider's stock after acquiring an additional 5,225 shares during the period. Parallel Advisors LLC's holdings in Amedisys were worth $592,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the business. MassMutual Private Wealth & Trust FSB raised its position in Amedisys by 56.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock worth $31,000 after acquiring an additional 120 shares during the period. Blue Trust Inc. raised its position in Amedisys by 55.1% during the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after acquiring an additional 124 shares during the period. Johnson Financial Group Inc. acquired a new position in Amedisys during the fourth quarter worth $55,000. Vestcor Inc acquired a new position in Amedisys during the fourth quarter worth $73,000. Finally, Venturi Wealth Management LLC grew its holdings in shares of Amedisys by 397.4% during the fourth quarter. Venturi Wealth Management LLC now owns 975 shares of the health services provider's stock worth $89,000 after buying an additional 779 shares in the last quarter. 94.36% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

AMED has been the subject of a number of research reports. Royal Bank of Canada reaffirmed an "outperform" rating and set a $100.00 target price on shares of Amedisys in a report on Wednesday, April 16th. Wall Street Zen lowered shares of Amedisys from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 24th. Finally, Stephens reaffirmed an "equal weight" rating and set a $101.00 target price on shares of Amedisys in a report on Tuesday, March 4th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to MarketBeat, Amedisys presently has an average rating of "Hold" and an average target price of $100.75.

Amedisys Trading Up 0.1%

Shares of AMED traded up $0.08 during mid-day trading on Wednesday, reaching $94.57. The stock had a trading volume of 367,543 shares, compared to its average volume of 409,479. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. Amedisys, Inc. has a 52-week low of $82.15 and a 52-week high of $98.95. The business's fifty day moving average is $93.55 and its 200 day moving average is $91.64. The firm has a market cap of $3.10 billion, a price-to-earnings ratio of 37.53, a P/E/G ratio of 1.78 and a beta of 0.96.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm had revenue of $594.78 million during the quarter, compared to analyst estimates of $597.43 million. During the same quarter in the prior year, the firm posted $1.03 earnings per share. Amedisys's quarterly revenue was up 4.1% on a year-over-year basis. On average, sell-side analysts predict that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.